![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 35
Zeitschriftenartikel
Reim, Daniel; Strobl, Andreas N.; Buchner, Christian; Schirren, Rebekka; Mueller, Werner; Luppa, Peter; Ankerst, Donna Pauler; Friess, Helmut und Novotny, Alexander
(2016):
Perioperative transfusion of leukocyte depleted blood products in gastric cancer patients negatively influences oncologic outcome A retrospective propensity score weighted analysis on 610 curatively resected gastric cancer patients.
In: Medicine, Bd. 95, Nr. 29, e4322
Giessen, C.; Laubender, Rüdiger P.; Ankerst, Donna Pauler; Stintzing, S.; Modest, D. P.; Mansmann, Ulrich und Heinemann, V.
(2013):
Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in mCRC: Literature-Based Analysis from 50 Randomized First-Line Trials.
In: Clinical Cancer Research, Bd. 19, Nr. 1: S. 225-235
Giessen, C.; Stintzing, S.; Laubender, Rüdiger P.; Ankerst, Donna Pauler; Schulz, C.; Moosmann, N.; Modest, D. P.; Schalhorn, A.; Fischer von Weikersthal, L. und Heinemann, V.
(2011):
Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer.
In: Clinical Colorectal Cancer, Bd. 10, Nr. 4: S. 317-324
Horster, S.; Laubender, Rüdiger P.; Lehmeyer, L.; Ankerst, Donna Pauler; Eberle, J.; Reinert, R.; Imohl, M.; van der Linden, M.; Schweiger, B. und Bogner, J. R.
(2010):
Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals.
In: Journal of Infection, Bd. 61, Nr. 6: S. 484-491
Rhodes, E. C.; Johnson-Pais, T. L.; Singer, F. R.; Ankerst, Donna Pauler; Bruder, J. M.; Wisdom, J.; Hoon, D. S.; Lin, E.; Bone, H. G.; Simcic, K. J. und Leach, R. J.
(2008):
Sequestosome 1 (SQSTM1) Mutations in Paget’s Disease of Bone from the United States.
In: Calcified Tissue International, Bd. 82, Nr. 4: S. 271-277
Heid, I. M.; Vollmert, C.; Kronenberg, F.; Huth, C.; Ankerst, Donna Pauler; Luchner, A.; Hinney, A.; Brönner, G.; Wichmann, H. E.; Illig, T.; Döring, A. und Hebebrand, J.
(2008):
Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study.
In: Obesity, Bd. 16, Nr. 2: S. 369-376
Blankenburg, Florian; Hatz, Rudolf; Nagel, Dorothea; Ankerst, Donna Pauler; Reinmiedl, Judith; Gruber, Christine; Seidel, Dietrich und Stieber, Petra
(2008):
Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer.
In: Tumor Biology, Nr. 4: S. 272-277
[PDF, 225kB]
Yildiz-Yesiloglu, Ayşegül; Guleryuz, S.; Ankerst, Donna Pauler; Ongur, D. und Renshaw, P. F.
(2008):
Protein Kinase C Inhibition in the Treatment of Mania: A Double-blind, Placebo-Controlled Trial of Tamoxifen.
In: Archives of general psychiatry, Bd. 65, Nr. 3: S. 255-263
Thompson, Ian M. und Ankerst, Donna Pauler
(2007):
Prostate-specific antigen in the early detection of prostate cancer.
In: CMAJ : Canadian Medical Association Journal, Bd. 176, Nr. 13: S. 697-702
Boeck, Stefan; Ankerst, Donna Pauler und Heinemann, Volker
(2007):
The role of adjuvant chemotherapy for patients with resected pancreatic cancer: Systematic review of randomized controlled trials and meta-analysis.
In: Oncology, Nr. 5-6: S. 314-321
[PDF, 224kB]
Parekh, D. J.; Ankerst, Donna Pauler; Baillargeon, J.; Higgins, B. A.; Platz, E. A.; Troyer, D.; Hernandez, J.; Leach, R. J.; Lokshin, A. und Thompson, Ian M.
(2007):
Assessment of 54 Biomarkers for Biopsy-Detectable Prostate Cancer.
In: Cancer Epidemiology, Biomarkers & Prevention, Bd. 16, Nr. 10: S. 1966-1972
Parekh, D. J.; Ankerst, Donna Pauler und Thompson, Ian M.
(2007):
Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies.
In: Journal of the National Cancer Institute, Bd. 99, Nr. 7: S. 496-497
Fliser, D.; Kollerits, B.; Neyer, U.; Ankerst, Donna Pauler; Lhotta, K.; Lingenhel, A.; Ritz, E. und Kronenberg, F.
(2007):
Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study.
In: Journal of the American Society of Nephrology, Bd. 18, Nr. 9: S. 2600-2608
Parekh, D. J.; Ankerst, Donna Pauler; Troyer, D.; Srivastava, S. und Thompson, Ian M.
(2007):
Biomarkers for prostate cancer detection.
In: Journal of Urology, Bd. 178, Nr. 6: S. 2252-2259
Bowen, D. J.; Fann, J. R.; Andersen, M. R.; Rhew, I. C.; Gralow, J. R.; Lewis, F. M.; Hunt, J. R.; Palomares, M.; Moinpour, Carol M. und Ankerst, Donna Pauler
(2007):
Recruiting Patients With Breast Cancer and Their Families to Behavioral Research in the Post-HIPAA Period.
In: Oncology Nursing Forum, Bd. 34, Nr. 5: S. 1049-1054
Ankerst, Donna Pauler und Thompson, Ian M.
(2007):
Understanding mixed messages about prostate specific antigen: biases in the evaluation of cancer biomarkers.
In: Journal of Urology, Bd. 177, Nr. 2: S. 426-427
Etzioni, R. D.; Ankerst, Donna Pauler; Weiss, N. S.; Inoue, L. Y. und Thompson, Ian M.
(2007):
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.
In: Journal of the National Cancer Institute, Bd. 99, Nr. 20: S. 1510-1515
Etzioni, R. D.; Ankerst, Donna Pauler und Thompson, Ian M.
(2007):
Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
In: Journal of the National Cancer Institute, Bd. 99, Nr. 6, 489-90; author reply 490
Markland, A. D.; Thompson, Ian M.; Ankerst, Donna Pauler; Higgins, B. A. und Kraus, S. R.
(2007):
Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican-American, and African-American men.
In: Urology, Bd. 69, Nr. 4: S. 697-702
Reed, A.; Ankerst, Donna Pauler; Pollock, B. H.; Thompson, Ian M. und Parekh, D. J.
(2007):
Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.
In: Journal of Urology, Bd. 178, Nr. 5: S. 1929-1932
Canby-Hagino, E.; Hernandez, J.; Brand, T. C.; Troyer, D. A.; Higgins, B. A.; Ankerst, Donna Pauler; Thompson, Ian M.; Leach, R. J. und Parekh, D. J.
(2007):
Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL.
In: Urology, Bd. 70, Nr. 4: S. 748-752
Moinpour, Carol M.; Darke, Amy K.; Donaldson, Gary W.; Thompson, Ian M.; Langley, Connie; Ankerst, Donna Pauler; Patrick, Donald L.; Ware, John E.; Ganz, Patricia A.; Shumaker, Sally A.; Lippman, Scott M. und Coltman, Charles A.
(2007):
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.
In: Journal of the National Cancer Institute, Bd. 99, Nr. 13: S. 1025-1035
Thompson, Ian M.; Ankerst, Donna Pauler; Chi, C.; Goodman, P. J.; Tangen, C. M.; Lucia, M. S.; Feng, Z.; Parnes, H. L. und Coltman, Charles A.
(2006):
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
In: Journal of the National Cancer Institute, Bd. 98, Nr. 8: S. 529-534
Thompson, Ian M.; Chi, C.; Ankerst, Donna Pauler; Goodman, P. J.; Tangen, C. M.; Lippman, Scott M.; Lucia, M. S.; Parnes, H. L. und Coltman, Charles A.
(2006):
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
In: Journal of the National Cancer Institute, Bd. 98, Nr. 16: S. 1128-1133
Parekh, D. J.; Ankerst, Donna Pauler; Higgins, B. A.; Hernandez, J.; Canby-Hagino, E.; Brand, T.; Troyer, D. A.; Leach, R. J. und Thompson, Ian M.
(2006):
External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.
In: Urology, Bd. 68, Nr. 6: S. 1152-1155
Wilson, C. S.; Davidson, G. S.; Martin, S. B.; Andries, E.; Potter, J.; Harvey, R.; Ar, K.; Xu, Y.; Kopecky, K. J.; Ankerst, Donna Pauler; Gundacker, H.; Slovak, M. L.; Mosquera-Caro, M.; Chen, I. M.; Stirewalt, D. L.; Murphy, M.; Schultz, F. A.; Kang, H.; Wang, X.; Radich, J. P.; Appelbaum, F. R.; Atlas, S. R.; Godwin, J. und Willman, C. L.
(2006):
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.
In: Blood, Bd. 108, Nr. 2: S. 685-696
Yildiz-Yesiloglu, Ayşegül und Ankerst, Donna Pauler
(2006):
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Bd. 30, Nr. 6: S. 969-995
Yildiz-Yesiloglu, Ayşegül und Ankerst, Donna Pauler
(2006):
Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
In: Psychiatry Research, Bd. 147, Nr. 1: S. 1-25
Berry, D. L.; Moinpour, Carol M.; Jiang, C. S.; Ankerst, Donna Pauler; Petrylak, D. P.; Vinson, L. V.; Lara, P. N.; Jones, S.; Taplin, M. E.; Burch, P. A.; Hussain, M. H. und Crawford, E. D.
(2006):
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
In: Journal of Clinical Oncology, Bd. 24, Nr. 18: S. 2828-2835
Ankerst, Donna Pauler und Thompson, Ian M.
(2006):
Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification.
In: Archivio Italiano di Urologia e Andrologia, Bd. 78, Nr. 4: S. 125-129
Ankerst, Donna Pauler und Thompson, Ian M.
(2006):
New answers from the Prostate Cancer Prevention Trial on the chemoprevention of prostate cancer.
In: Archivio Italiano di Urologia e Andrologia, Bd. 78, Nr. 4: S. 154-156
Ankerst, Donna Pauler und Thompson, Ian M.
(2006):
Merging digital rectal exam, family history, age and prostate-specific antigen to create a decision-making tool.
In: Archivio Italiano di Urologia e Andrologia, Bd. 78, Nr. 4: S. 143-146
Ankerst, Donna Pauler und Engel, Jutta
(2006):
Status of quality of life in breast cancer research before, during and beyond treatment.
In: Expert Review of Pharmacoeconomics and Outcomes Research, Bd. 6, Nr. 2: S. 207-214
Baillargeon, J.; Platz, E. A.; Rose, D. P.; Pollock, B. H.; Ankerst, Donna Pauler; Haffner, S.; Higgins, B. A.; Lokshin, A.; Troyer, D.; Hernandez, J.; Lynch, S.; Leach, R. J. und Thompson, Ian M.
(2006):
Obesity, adipokines, and prostate cancer in a prospective population-based study.
In: Cancer Epidemiology, Biomarkers & Prevention, Bd. 15, Nr. 7: S. 1331-1335
Petrylak, D. P.; Ankerst, Donna Pauler; Jiang, C. S.; Tangen, C. M.; Hussain, M. H.; Lara, P. N.; Jones, J. A.; Taplin, M. E.; Burch, P. A.; Kohli, M.; Benson, M. C.; Small, E. J.; Raghavan, D. und Crawford, E. D.
(2006):
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
In: Journal of the National Cancer Institute, Bd. 98, Nr. 8: S. 516-521